Methods for treating renal disease
- 专利权人:
- Beth Israel Deaconess Medical Center; Inc.
- 发明人:
- David J. Friedman,Martin R. Pollak
- 申请号：
- US14646055
- 公开号：
- US10130632B2
- 申请日:
- 2013.11.20
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- The invention features methods for treating or reducing the likelihood of developing a renal disease by administering to a subject in need thereof an agent that decreases expression of a pathogenic APOL1. The agents of the method target various signaling pathways and decrease the level of the pathogenic APOL1 polypeptide.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- USE OF PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF EGFR DEPENDENT DISEASES OR DISEASES THAT HAVE ACQUIRED RESISTANCE TO AGENTS THAT TARGET EGFR FAMILY MEMBERS
- METHODS OF TREATING GRAFT-VERSUS-HOST DISEASE
- Use of pyrimidine derivatives for the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members
- Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members
- Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members
